Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 520

1.

Stage I-II Nodular Lymphocyte-Predominant Hodgkin Lymphoma: a Multi-institutional Experience of Adult Patients by ILROG.

Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang RW, Dickinson M, Ng A, Roberts KB, Gao S, Balogh AG, Ricardi U, Levis M, Casulo C, Stolten M, Specht L, Plastaras JP, Wright C, Kelsey CR, Brady JL, Mikhaeel NG, Hoppe BS, Terezakis S, Picardi M, Della Pepa R, Kirova Y, Akhtar S, Maghfoor I, Koenig JL, Jackson C, Song E, Sehgal S, Advani R, Natkunam Y, Constine LS, Eich HT, Wirth A, Hoppe RT.

Blood. 2020 Mar 25. pii: blood.2019003877. doi: 10.1182/blood.2019003877. [Epub ahead of print]

PMID:
32211877
2.

Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma.

Bates JE, Parikh RR, Mendenhall NP, Morris CG, Hoppe RT, Constine LS, Hoppe BS.

Int J Radiat Oncol Biol Phys. 2020 Mar 12. pii: S0360-3016(20)30896-8. doi: 10.1016/j.ijrobp.2020.02.642. [Epub ahead of print]

PMID:
32173399
3.

Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal.

Busque S, Scandling JD, Lowsky R, Shizuru J, Jensen K, Waters J, Wu HH, Sheehan K, Shori A, Choi O, Pham T, Fernandez Vina MA, Hoppe R, Tamaresis J, Lavori P, Engleman EG, Meyer E, Strober S.

Sci Transl Med. 2020 Jan 29;12(528). pii: eaax8863. doi: 10.1126/scitranslmed.aax8863.

PMID:
31996467
4.

Keep the Dose Low. Keep the Fields Tight.

Hoppe RT.

Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):15. doi: 10.1016/j.ijrobp.2018.04.022. No abstract available.

PMID:
31836076
5.

Correction to "Mechanistic Studies of the Streptomyces bingchenggensis Aldolase-Dehydratase: Implications for Substrate and Reaction Specificity in the Acetoacetate Decarboxylase-like Superfamily".

Mydy LS, Hoppe RW, Hagemann TM, Schwabacher AW, Silvaggi NR.

Biochemistry. 2019 Dec 10;58(49):5022. doi: 10.1021/acs.biochem.9b00984. Epub 2019 Dec 2. No abstract available.

PMID:
31790220
6.

Tomayto, tomahto: prescription dose and mean heart dose in evaluating the cardiac impact of involved-field radiation therapy for Hodgkin lymphoma survivors.

Bates JE, Flampouri S, Hoppe RT, Li Z, Mendenhall NP, Hoppe BS.

Acta Oncol. 2019 Dec;58(12):1783-1785. doi: 10.1080/0284186X.2019.1657943. Epub 2019 Sep 6. No abstract available.

PMID:
31742489
7.

The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy Era.

Hoppe BS, Bates JE, Mendenhall NP, Morris CG, Louis D, Ho MW, Hoppe RT, Shaikh M, Li Z, Flampouri S.

Pract Radiat Oncol. 2019 Oct 2. pii: S1879-8500(19)30279-6. doi: 10.1016/j.prro.2019.09.015. [Epub ahead of print]

8.

The Influences of Adherence to Tamoxifen and CYP2D6 Pharmacogenetics on Plasma Concentrations of the Active Metabolite (Z)-Endoxifen in Breast Cancer.

Nardin JM, Schroth W, Almeida TA, Mürdter T, Picolotto S, Vendramini ECL, Hoppe R, Kogin JP, Miqueleto D, de Moraes SDR, Schwab M, Pecoits-Filho RF, Brauch H, Casali-da-Rocha JC.

Clin Transl Sci. 2020 Mar;13(2):284-292. doi: 10.1111/cts.12707. Epub 2019 Nov 9.

9.

Mechanistic Studies of the Streptomyces bingchenggensis Aldolase-Dehydratase: Implications for Substrate and Reaction Specificity in the Acetoacetate Decarboxylase-like Superfamily.

Mydy LS, Hoppe RW, Hagemann TM, Schwabacher AW, Silvaggi NR.

Biochemistry. 2019 Oct 8;58(40):4136-4147. doi: 10.1021/acs.biochem.9b00652. Epub 2019 Sep 20. Erratum in: Biochemistry. 2019 Dec 10;58(49):5022.

PMID:
31524380
10.

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort.

Spinner MA, Kennedy VE, Tamaresis JS, Lavori PW, Arai S, Johnston LJ, Meyer EH, Miklos DB, Muffly LS, Negrin RS, Rezvani AR, Shizuru JA, Weng WK, Hoppe RT, Strober S, Lowsky R.

Blood Adv. 2019 Aug 27;3(16):2454-2464. doi: 10.1182/bloodadvances.2019000297.

11.

20 Gy Versus 30 Gy: Will it Make a Difference?

Hoppe RT.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):102-103. doi: 10.1016/j.ijrobp.2019.06.008. No abstract available.

PMID:
31422803
12.

Low-dose total skin electron beam therapy for refractory cutaneous CD30 positive lymphoproliferative disorders.

Panjwani N, Yoo CH, Wang E, Khodadoust MS, Kim YH, Hoppe RT, Hiniker SM.

J Dermatolog Treat. 2019 Jun 27:1-3. doi: 10.1080/09546634.2019.1628913. [Epub ahead of print]

PMID:
31179774
13.

Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.

Binkley MS, Brady JL, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Ahmed S, MacManus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova YM, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Mikhaeel NG, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):522-529. doi: 10.1016/j.ijrobp.2019.03.004. Epub 2019 Mar 8.

PMID:
30858143
14.

Volumetric Modulated Arc Therapy and 3-Dimensional Printed Bolus in the Treatment of Refractory Primary Cutaneous Gamma Delta Lymphoma of the Bilateral Legs.

Obeid JP, Gutkin PM, Lewis J, Skinner L, Wang EB, Khodadoust MS, Kim YH, Weng WK, Hoppe RT, Hiniker SM.

Pract Radiat Oncol. 2019 Jul - Aug;9(4):220-225. doi: 10.1016/j.prro.2019.02.016. Epub 2019 Mar 2. No abstract available.

PMID:
30836188
15.

Machine-readable Yin-Yang imbalance: traditional Chinese medicine syndrome computer modeling based on three-dimensional noninvasive cardiac electrophysiology imaging.

Cen W, Hoppe R, Sun A, Ding H, Gu N.

J Int Med Res. 2019 Apr;47(4):1580-1591. doi: 10.1177/0300060518824247. Epub 2019 Mar 5.

16.

Video-Based Communication Assessment: Development of an Innovative System for Assessing Clinician-Patient Communication.

Mazor KM, King AM, Hoppe RB, Kochersberger AO, Yan J, Reim JD.

JMIR Med Educ. 2019 Feb 14;5(1):e10400. doi: 10.2196/10400.

17.

Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin.

Kheterpal MK, Dai J, Geller S, Pulitzer M, Ni A, Myskowski PL, Moskowitz A, Kim J, Hong EK, Fong S, Hoppe RT, Kim YH, Horwitz SM.

J Am Acad Dermatol. 2019 Oct;81(4):970-976. doi: 10.1016/j.jaad.2019.01.037. Epub 2019 Jan 29.

PMID:
30703460
18.

Cancer-Associated Intermediate Conductance Ca2+-Activated K⁺ Channel KCa3.1.

Mohr CJ, Steudel FA, Gross D, Ruth P, Lo WY, Hoppe R, Schroth W, Brauch H, Huber SM, Lukowski R.

Cancers (Basel). 2019 Jan 17;11(1). pii: E109. doi: 10.3390/cancers11010109. Review.

19.

Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.

Moding EJ, Advani R, Rosenberg SA, Hoppe RT.

Radiother Oncol. 2018 Dec;129(3):507-512. doi: 10.1016/j.radonc.2018.06.033. Epub 2018 Jul 6.

PMID:
30539763
20.

Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG.

Brady JL, Binkley MS, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Mac Manus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova Y, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Hoppe RT, Mikhaeel NG.

Blood. 2019 Jan 17;133(3):237-245. doi: 10.1182/blood-2018-04-843540. Epub 2018 Nov 16. Erratum in: Blood. 2019 Jul 18;134(3):331.

Supplemental Content

Loading ...
Support Center